In breast cancer, METTL14 and ZC3H13 were down-regulated, indicating a positive correlation between the expression of METTL14 and ZC3H13 positively correlated with various kinds of immune cells, including macrophages, T cells and DCs [32]. Here, METTL14 is linked to breast carcinoma.